IBM revenue growth slows amid AI concerns; shares fall

IBM's Q1 revenue rose 9% to $15.92 billion, below the prior quarter's 12.2% growth pace, as software revenue growth slowed to 11.3% amid AI disruption fears. The company still beat estimates for revenue ($15.62 billion consensus) and adjusted EPS ($1.91 vs. $1.81 expected), while infrastructure revenue climbed 15.2% to $3.33 billion. Shares fell 6% after hours as investors focused on the slower software growth and AI competition risk.

Analysis

The market is effectively drawing a line between “AI threat to legacy software” and “AI-enabled modernization moat.” IBM’s weak spot is not generic software demand so much as pricing power in the parts of the stack most exposed to code-generation and workflow automation; that makes the multiple vulnerable because investors typically underwrite software businesses on durable high-margin growth, not just maintenance revenue. The offset is that mainframe refresh cycles can become more valuable, not less, if AI increases the pace of application rewrites and the urgency of migrating/modernizing mission-critical workloads.

The second-order winner is likely the broader mainframe ecosystem: services, integration, security, and tooling vendors that sit around modernization projects should see longer deal cycles but larger wallets. A subtle implication is that AI tools may compress low-end software spend while expanding spend on systems that govern, secure, and orchestrate AI-assisted changes; that favors incumbents with deep enterprise permissions and compliance relationships. If IBM’s modernization tools really accelerate consumption, the near-term bear case on the software segment may be overstated, but the market will need evidence across multiple quarters before re-rating the name.

Risk is asymmetric over the next 1-2 quarters because the selloff is likely to be driven by narrative as much as fundamentals. Any sign of slower Red Hat growth, weaker net retention, or soft guidance would reinforce the view that AI is disintermediating the software stack faster than IBM can monetize modernization. Conversely, if infrastructure strength persists and management can show that AI-assisted mainframe work pulls through higher consumption, this becomes a “bad headline, better business mix” setup rather than a structural deterioration.

Consensus is probably missing that IBM’s mainframe franchise can act as a hedge against the very AI disruption that is pressuring the software valuation. The overreaction risk is highest if investors extrapolate one quarter of slower software growth into a durable erosion story, when the more likely outcome is a mix shift: slower growth in commoditizable software, but improving economics in infrastructure and modernization services. That makes the stock a candidate for a tactical fade on weakness rather than a clean long until the market sees proof of re-acceleration.

Key Decisions for Investors

• Short IBM into post-earnings strength or sell calls against stock: 2-6 week horizon, targeting downside if the market prices in a software-disruption narrative before guidance is digested; risk is a management-led rebound if modernization commentary gains traction.
• Pair trade: long HPE or ANET vs short IBM over 1-3 months if you want AI infrastructure exposure without the software overhang; IBM benefits from modernization, but the multiple should lag higher-beta infrastructure names if AI capex remains the dominant theme.
• For existing IBM longs, add a downside hedge with near-dated puts into the next catalyst window; the stock can be sentiment-driven for several sessions even if fundamentals are only modestly weaker, so protect against a 5-10% drawdown.
• Watch for a long entry only after evidence of stable software growth and stronger mainframe consumption in the next quarter; if confirmed, IBM becomes a low-drama, cash-generative compounder with a de-risked AI narrative.